Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in premenopausal women
Journal title: Eurasian Chemical Communications
Authors: Mehdi Nabati
Subject(s): Chemistry, Multidisciplinary, Chemistry, Organic